IS5878A - Powder for lungs - Google Patents

Powder for lungs

Info

Publication number
IS5878A
IS5878A IS5878A IS5878A IS5878A IS 5878 A IS5878 A IS 5878A IS 5878 A IS5878 A IS 5878A IS 5878 A IS5878 A IS 5878A IS 5878 A IS5878 A IS 5878A
Authority
IS
Iceland
Prior art keywords
lungs
powder
Prior art date
Application number
IS5878A
Other languages
Icelandic (is)
Inventor
Clark Andrew
Kuo Mei-Chang
Lalor Cecily
John Aldous Barry
Original Assignee
Nektar Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics filed Critical Nektar Therapeutics
Publication of IS5878A publication Critical patent/IS5878A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
IS5878A 1998-09-14 2001-03-05 Powder for lungs IS5878A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14
PCT/US1999/021109 WO2000015262A1 (en) 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery

Publications (1)

Publication Number Publication Date
IS5878A true IS5878A (en) 2001-03-05

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5878A IS5878A (en) 1998-09-14 2001-03-05 Powder for lungs

Country Status (44)

Country Link
EP (1) EP1117442A1 (en)
JP (1) JP2002524535A (en)
KR (1) KR20010075063A (en)
CN (1) CN1317977A (en)
AP (1) AP1374A (en)
AR (1) AR022090A1 (en)
AU (1) AU753014B2 (en)
BG (1) BG105430A (en)
BR (1) BR9913722A (en)
CA (1) CA2343920A1 (en)
CO (1) CO5130023A1 (en)
CZ (1) CZ2001829A3 (en)
DZ (1) DZ2892A1 (en)
EA (1) EA003476B1 (en)
EE (1) EE200100151A (en)
GE (1) GEP20043257B (en)
GT (1) GT199900156A (en)
HK (1) HK1042231A1 (en)
HN (1) HN1999000159A (en)
HR (1) HRP20010189A2 (en)
HU (1) HUP0103837A3 (en)
ID (1) ID28845A (en)
IL (2) IL141562A0 (en)
IS (1) IS5878A (en)
LT (1) LT4897B (en)
LV (1) LV12658B (en)
MA (1) MA25590A1 (en)
MY (1) MY129282A (en)
NO (1) NO20011251L (en)
NZ (1) NZ510168A (en)
OA (1) OA11781A (en)
PA (1) PA8481901A1 (en)
PE (1) PE20001061A1 (en)
PL (1) PL195574B1 (en)
SA (1) SA99200718B1 (en)
SK (1) SK3442001A3 (en)
TN (1) TNSN99173A1 (en)
TR (1) TR200101182T2 (en)
TW (1) TWI226248B (en)
UA (1) UA76085C2 (en)
UY (1) UY25711A1 (en)
WO (1) WO2000015262A1 (en)
YU (1) YU24201A (en)
ZA (1) ZA200101995B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
HK1049621A1 (en) 1999-06-09 2003-05-23 罗伯特‧E‧希弗斯 Supercritical fluid-assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Pharmaceuticals, Inc. Delivery of drug esters through an inhalation route
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
CA2465675C (en) 2001-11-20 2008-06-10 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
WO2003072734A2 (en) 2002-02-25 2003-09-04 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
CA2491129A1 (en) * 2002-07-03 2004-01-15 Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
JP2006513238A (en) * 2002-12-19 2006-04-20 ファルマシア・コーポレーション Non-hygroscopic formulations containing hygroscopic drugs
DE10338403A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
BRPI0510119A (en) 2004-04-23 2007-09-25 Cydex Inc formulation for dpi containing sulfoaquil cyclodextrin ether
UA95903C2 (en) * 2005-02-24 2011-09-26 Дифьюжен Фармасьютикалз Ллк Trans carotenoids, their synthesis, formulation and uses
KR20070110418A (en) * 2005-03-09 2007-11-16 오노 야꾸힝 고교 가부시키가이샤 Particles and Formulations Containing the Particles
SI2952197T1 (en) 2005-10-26 2017-09-29 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20100269819A1 (en) * 2006-08-14 2010-10-28 Sievers Robert E Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
CN101541311B (en) * 2006-10-25 2013-01-23 大日本住友制药株式会社 Granular preparation prevented from caking
EP1925295A1 (en) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stable powder formulation containing a new antichinolinergic agent
EP3483140A1 (en) 2007-04-13 2019-05-15 Diffusion Pharmaceuticals LLC Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
EA201070544A1 (en) 2007-10-31 2010-12-30 Диффьюжн Фармасьютикалз Ллс NEW CLASS OF THERAPEUTIC SUBSTANCES STRENGTHENING THE DIFFUSION OF LOW MOLECULAR COMPOUNDS
ES2661215T3 (en) * 2009-05-20 2018-03-28 Aeras Viral compositions; immunogens; spray dried; stable
KR101875843B1 (en) 2009-06-22 2018-07-06 디퓨젼 파마슈티컬즈 엘엘씨 Diffusion enhancing compounds and their use alone or with thrombolytics
CN105287473A (en) 2010-06-02 2016-02-03 扩散药品有限公司 Oral formulations of bipolar trans carotenoids and uses thereof
SG11201406208QA (en) 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
BR112015010601B1 (en) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
AU2015338717B2 (en) 2014-10-31 2018-12-20 Glaxosmithkline Intellectual Property Development Limited Powder formulation
WO2017165667A1 (en) 2016-03-24 2017-09-28 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery
EP4493276A4 (en) * 2022-03-18 2025-03-05 Pulmocures Ilac Egitim Danismanlik A.S. DOSAGE FORMS OF ACTIVE SUBSTANCES USED AGAINST VIRAL DISEASES IN A DRY POWDER INHALER DEVICE FOR SYMPTOMS CAUSED BY COVID-19 AND OTHER VIRAL PULMONARY DISEASES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
EP0611567B1 (en) * 1992-06-12 2002-08-28 Teijin Limited Ultrafine powder for inhalation and production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
DE69732306T2 (en) * 1997-01-16 2006-01-12 Massachusetts Institute Of Technology, Cambridge PREPARATION OF PARTICLE MEDICINES FOR INHALATION
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
JP2002524535A (en) 2002-08-06
MA25590A1 (en) 2002-12-31
WO2000015262A1 (en) 2000-03-23
YU24201A (en) 2003-08-29
PE20001061A1 (en) 2000-10-08
MY129282A (en) 2007-03-30
IL141562A (en) 2007-07-24
CA2343920A1 (en) 2000-03-23
CN1317977A (en) 2001-10-17
ID28845A (en) 2001-07-05
HRP20010189A2 (en) 2005-04-30
CZ2001829A3 (en) 2001-09-12
CO5130023A1 (en) 2002-02-27
PL195574B1 (en) 2007-10-31
LT4897B (en) 2002-02-25
PA8481901A1 (en) 2002-04-25
LT2001021A (en) 2001-11-26
OA11781A (en) 2005-07-26
BG105430A (en) 2001-12-29
HUP0103837A2 (en) 2002-05-29
AP1374A (en) 2005-02-28
HK1042231A1 (en) 2002-08-09
NZ510168A (en) 2003-09-26
ZA200101995B (en) 2002-03-11
AU753014B2 (en) 2002-10-03
TNSN99173A1 (en) 2005-11-10
EE200100151A (en) 2002-06-17
LV12658B (en) 2001-09-20
LV12658A (en) 2001-05-20
EP1117442A1 (en) 2001-07-25
UA76085C2 (en) 2006-07-17
GT199900156A (en) 2001-03-07
SA99200718B1 (en) 2006-11-04
PL346768A1 (en) 2002-02-25
GEP20043257B (en) 2004-06-25
AP2001002093A0 (en) 2001-03-31
TWI226248B (en) 2005-01-11
DZ2892A1 (en) 2003-12-15
UY25711A1 (en) 1999-11-17
NO20011251L (en) 2001-04-17
AR022090A1 (en) 2002-09-04
TR200101182T2 (en) 2001-09-21
HUP0103837A3 (en) 2002-11-28
IL141562A0 (en) 2002-03-10
NO20011251D0 (en) 2001-03-13
EA003476B1 (en) 2003-06-26
HN1999000159A (en) 1999-11-11
BR9913722A (en) 2001-05-29
KR20010075063A (en) 2001-08-09
EA200100300A1 (en) 2001-10-22
AU6039799A (en) 2000-04-03
SK3442001A3 (en) 2001-11-06

Similar Documents

Publication Publication Date Title
EE04420B1 (en) Powder inhaler
ATE485812T1 (en) PRESSURE-DOSE INHALERS
ID24472A (en) MAKING POWDER AGLOMERATE
NO990272L (en) Powder inhaler
IS5487A (en) inhaler
DE69922643D1 (en) tracheostomy
ATE321483T1 (en) CAN
ID18427A (en) POWDER POWDER
DK1070058T3 (en) (4-Arylsulfonylamino) tetrahydropyran-4-carboxylsyrehydroxamider
ID23458A (en) NEFAZODON AVAILABLE FORM
DE69941870D1 (en) L-SOUND FORMAT
EP1124578A4 (en) NEW IMMUNADJUVANZIA
ID23735A (en) TABLET TROVAFLOKSASIN MESILAT
NO20004309D0 (en) HÕrmiddel
DE69823561D1 (en) inhalers
DE59909297D1 (en) Carbonyleisensilizid powder
FR2763507B1 (en) INHALER
DE69917842D1 (en) INHALATION APPARATUS
DE69921275D1 (en) inhaler
DE69824327D1 (en) inhaler
FR2782671B3 (en) DELIVERED
NO20003182L (en) Powder Inhalation Procedure
DE69937138D1 (en) COMPOSITE POWDER
ID19844A (en) POWDER COMPONENTS
DE59909647D1 (en) tracheal